Clinical Trials for Relapsed Refractory Multiple Myeloma

Find clinical trials for relapsed refractory multiple myeloma. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

ELISA in Relapsed/Refractory MM

NCT ID: NCT06832865

This clinical trial, called ELISA in Relapsed/Refractory Multiple Myeloma, is studying a new treatment combination for patients with relapsed and refractory multiple myeloma (RRMM). Specifically, i...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

NCT ID: NCT06783816

This clinical trial is studying a new treatment for certain types of blood cancers, including Acute Lymphocytic Leukemia, lymphoma, and multiple myeloma that have not responded to previous treatmen...

Recruiting

Phase: NA Type: interventional Locations: Taiyuan, Shanxi, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions